Blocking a protein could halt the growth of fast-growing cancers

Preventing the cell’s protein factories from making the notorious cancer-causing protein MYC could stop out-of-control tumors.

PhRMA urges court to stop government drug price negotiations before they start

Industry group PhRMA yesterday asked a Texas district court to halt CMS’ incoming drug price negotiations before they kick off in earnest next month. The

August 12, 2023

Lutris wins FDA orphan drug tag for EGFR inhibitor-induced rash candidate – Pharmaceutical Technology

Share this article According to Lutris’ CEO, approximately 75% of cancer patients taking EGFR inhibitors develop some form of acneiform rash. Credit: sruilk via Getty

February 29, 2024

Genentech joins suits against STD clinics it says get ‘unlawful’ 340B discounts

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.